Circulation, Vol 65, 1072-1077, Copyright © 1982 by American Heart Association
JT Flaherty, PA Magee, TL Gardner, A Potter and NP MacAllister
The present study was designed to test the hypothesis that i.v.
nitroglycerin is as effective as sodium nitroprusside for managing acute
hypertension early after coronary artery bypass surgery. Seventeen patients
received both nitroglycerin and nitroprusside in a randomized crossover
protocol. Infusion rates were increased stepwise to lower mean arterial
pressures comparably with each drug. In 14 of 17 patients, similar infusion
rates of the two vasodilators resulted in equal lowering of both blood
pressure and systemic vascular resistance. In the remaining three patients,
very high infusion rates of nitroglycerin were required and achieved only
20-50% of nitroprusside's response in two of three. Hemodynamic responses
to the two vasodilators were similar, except that nitroglycerin increased
cardiac output more than nitroprusside did. In contrast, pulmonary gas
exchange responses differed in that nitroglycerin improved intrapulmonary
shunting, while nitroprusside worsened it. Similarly, nitroglycerin
resulted in a significantly smaller increase in the alveolar arterial
oxygen gradient than did nitroprusside. These results suggest that in the
majority of patients, i.v. nitroglycerin was as effective as nitroprusside
in controlling acute hypertension after coronary artery bypass surgery. In
addition, nitroglycerin appeared to have more favorable effects on
pulmonary gas exchange. Because nitroglycerin has more beneficial effects
on intercoronary collateral blood flow in the setting of regional ischemia,
it may be preferable to nitroprusside in patients with ischemic heart
disease.
ARTICLES
Comparison of intravenous nitroglycerin and sodium nitroprusside for treatment of acute hypertension developing after coronary artery bypass surgery
This article has been cited by other articles:
![]() |
F. Toraman, H. Karabulut, O. Goksel, S. Evrenkaya, S. Tarcan, and C. Alhan Comparison of Antihypertensives after Coronary Artery Surgery Asian Cardiovasc Thorac Ann, December 1, 2005; 13(4): 302 - 306. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. T. Bethea, D. D. Yuh, J. V. Conte, and W. A. Baumgartner Heart Transplantation Card. Surg. Adult, January 1, 2003; 2(2003): 1427 - 1460. [Full Text] |
||||
![]() |
J. G. van der Stroom Influence of Vasodilator Drugs on Perioperative Blood Pressure Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 204 - 221. [Abstract] [PDF] |
||||
![]() |
M. Nordlander, M. Pfaffendorf, and H. B. van Wezel Calcium Antagonists for Perioperative Blood Pressure Control Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 1998; 2(3): 231 - 242. [Abstract] [PDF] |
||||
![]() |
RayW. Gifford Jr Management of Hypertensive Crises JAMA, August 14, 1991; 266(6): 829 - 835. [Abstract] [PDF] |
||||
![]() |
C. V. S. Ram and D. Hyman Hypertensive Crises J Intensive Care Med, May 1, 1987; 2(3): 151 - 162. [Abstract] [PDF] |
||||
![]() |
R. K. Ferguson and P. H. Vlasses Hypertensive Emergencies and Urgencies JAMA, March 28, 1986; 255(12): 1607 - 1613. [Abstract] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 1982 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |